Gempharmatech Co. Ltd. A Capital Reinvestment Ratio
Gempharmatech Co. Ltd. A capital reinvestment ratio. Gempharmatech Co. Ltd. A (688046) has a Capital Reinvestment Ratio of 1.26x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥90.31 Million) in capital expenditures (CN¥113.68 Million). See Gempharmatech Co. Ltd. A (688046) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Gempharmatech Co. Ltd. A (2019–2024)
Capital reinvestment ratio of Gempharmatech Co. Ltd. A from 2019 to 2024. This chart tracks Gempharmatech Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. See Gempharmatech Co. Ltd. A (688046) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Gempharmatech Co. Ltd. A Capital Reinvestment Ratio by Year (2019–2024)
Gempharmatech Co. Ltd. A capital reinvestment ratio by year from 2019 to 2024. For the full cash flow conversion analysis, see 688046 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.26x | CN¥90.31 Million | CN¥113.68 Million | ▼ -28.7% |
| 2023 | 1.77x | CN¥116.57 Million | CN¥205.90 Million | ▼ -1.6% |
| 2022 | 1.80x | CN¥105.98 Million | CN¥190.31 Million | ▲ +128.4% |
| 2021 | 0.79x | CN¥113.31 Million | CN¥89.07 Million | ▼ -38.9% |
| 2020 | 1.29x | CN¥129.79 Million | CN¥167.07 Million | ▲ +83.6% |
| 2019 | 0.70x | CN¥65.12 Million | CN¥45.66 Million | — |